Patents by Inventor Adrian Timmers

Adrian Timmers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF PROGRANULIN ASSOCIATED NEURODEGENERATIVE DISEASES OR DISORDERS
    Publication number: 20210147872
    Abstract: The disclosure provides, in part, optimally-modified progranulin (PGRN) cDNA and associated genetic elements for use in recombinant adeno-associated virus (rAAV)-based gene therapy for neurodegenerative disorders characterized by cognitive disruption, behavioral impairment, and deficient lysosomal storage, including familial frontotemporal dementia (FTD), frontotemporal lobar degeneration (FTLD), neuronal ceroid lipofuscinosis (NCL), or Alzheimer's disease (AD).
    Type: Application
    Filed: October 22, 2020
    Publication date: May 20, 2021
    Inventors: Juan Li, Tanaz Farivar, Savitri Mandapadi, Steven Pennock, Mark Shearman, Judith Newmark, Adrian Timmers
  • ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF GENETIC HEARING LOSS
    Publication number: 20210095313
    Abstract: Described herein are optimally-modified GJB2 cDNA and associated genetic elements for use in recombinant adeno-associated virus (rAAV)-based gene therapy for the treatment of genetic hearing loss.
    Type: Application
    Filed: September 30, 2020
    Publication date: April 1, 2021
    Inventors: Chris Bartolome, Luis David Jaramillo, Adrian Timmers, Steven Pennock, Mark Shearman